Home » Stocks » HTGM

HTG Molecular Diagnostics, Inc. (HTGM)

Stock Price: $6.04 USD 0.67 (12.48%)
Updated Jul 26, 2021 10:15 AM EDT - Market open
Market Cap 39.02M
Revenue (ttm) 7.76M
Net Income (ttm) -20.26M
Shares Out 6.04M
EPS (ttm) -4.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 26
Last Price $6.04
Previous Close $5.37
Change ($) 0.67
Change (%) 12.48%
Day's Open 5.80
Day's Range 5.75 - 6.38
Day's Volume 165,962
52-Week Range 3.50 - 11.25

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on Jul...

3 days ago - GlobeNewsWire

HTG Molecular Diagnostics Inc (NASDAQ: HTGM) has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements with its first two Early Adopter Program (EAP) col...

1 month ago - Benzinga

TUCSON, Ariz., May 24, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HTG ...

2 months ago - GlobeNewsWire

Call scheduled for today, May 13, at 4:30 pm ET Call scheduled for today, May 13, at 4:30 pm ET

2 months ago - GlobeNewsWire

TUCSON, Ariz., May 04, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report...

2 months ago - GlobeNewsWire

TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain prel...

3 months ago - GlobeNewsWire

Call scheduled for today, March 25, at 4:30pm ET Call scheduled for today, March 25, at 4:30pm ET

4 months ago - GlobeNewsWire

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will repo...

4 months ago - GlobeNewsWire

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of Deciph...

Other stocks mentioned: BIOC, BMKDF
4 months ago - Benzinga

TUCSON, Ariz., Feb. 26, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has compl...

5 months ago - GlobeNewsWire

Timothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director Timothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director

6 months ago - GlobeNewsWire

TUCSON, Ariz., Dec. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

6 months ago - GlobeNewsWire

TUCSON, Ariz., Dec. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

7 months ago - GlobeNewsWire

TUCSON, Ariz., Dec. 08, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

7 months ago - GlobeNewsWire

TUCSON, Ariz., Nov. 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that as a result o...

8 months ago - GlobeNewsWire

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Shares of HTG Molecular Diagnostics (NASDAQ:HTGM) decreased 3.2% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 53.33% year over year to ($0.07)...

8 months ago - Benzinga

Call scheduled for today, November 10, at 4:30pm ET Call scheduled for today, November 10, at 4:30pm ET

8 months ago - GlobeNewsWire

TUCSON, Ariz., Nov. 02, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the completi...

8 months ago - GlobeNewsWire

TUCSON, Ariz., Oct. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will repor...

8 months ago - GlobeNewsWire

TUCSON, Ariz., Sept. 08, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced John Lubniewski, ...

10 months ago - GlobeNewsWire

TUCSON, Ariz., Aug. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commer...

11 months ago - GlobeNewsWire

TUCSON, Ariz., Aug. 14, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update r...

11 months ago - GlobeNewsWire

HTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Shares of HTG Molecular Diagnostics (NASDAQ:HTGM) were flat in after-market trading after the company reported Q2 results.

11 months ago - Benzinga

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of 0.00% and 3.32%, respectively, for the quarter ended June 2020.

11 months ago - Zacks Investment Research

Call scheduled for today, August 11, at 4:30pm ET Call scheduled for today, August 11, at 4:30pm ET

11 months ago - GlobeNewsWire

TUCSON, Ariz., Aug. 10, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signin...

11 months ago - GlobeNewsWire

On Tuesday, August 11, HTG Molecular Diagnostics (NASDAQ: HTGM) will report its last quarter's earnings.

11 months ago - Benzinga

TUCSON, Ariz., Aug. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will repor...

11 months ago - GlobeNewsWire

TUCSON, Ariz., Aug. 04, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-la...

11 months ago - GlobeNewsWire

Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform Entire HTG RUO profiling assay menu now available for use on both Illumina’s and ...

11 months ago - GlobeNewsWire

TUCSON, Ariz., July 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch...

11 months ago - GlobeNewsWire

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

11 months ago - Zacks Investment Research

Researchers at University of Pennsylvania Perelman School of Medicine and Charité University Hospitals, Berlin recognized for cutting edge work in autoimmune diseases Researchers at University of Pennsy...

1 year ago - GlobeNewsWire

TUCSON, Ariz., June 25, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it ha...

1 year ago - GlobeNewsWire

TUCSON, Ariz., June 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced its HTG Ed...

1 year ago - GlobeNewsWire

Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas

1 year ago - GlobeNewsWire

TUCSON, Ariz., June 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signin...

1 year ago - GlobeNewsWire

Top Ranked Momentum Stocks to Buy for May 14th

Other stocks mentioned: ALDX, ECOM, GLUU
1 year ago - Zacks Investment Research

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

HTG Molecular Diagnostics Inc (HTGM) delivered earnings and revenue surprises of 0.00% and -2.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the st...

1 year ago - Zacks Investment Research

Call scheduled for today, May 13, at 4:30pm ET Call scheduled for today, May 13, at 4:30pm ET

1 year ago - GlobeNewsWire

HTG Molecular Diagnostics Inc (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

TUCSON, Ariz., Feb. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the HTG ...

1 year ago - GlobeNewsWire

TUCSON, Ariz., Feb. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the repr...

1 year ago - GlobeNewsWire

TUCSON, Ariz., Jan. 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has rec...

1 year ago - GlobeNewsWire

About HTGM

HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's marketed panels include HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq D... [Read more...]

Industry
Diagnostics & Research
IPO Date
May 6, 2015
CEO
John Lubniewski
Employees
83
Stock Exchange
NASDAQ
Ticker Symbol
HTGM
Full Company Profile

Financial Performance

In 2020, HTGM's revenue was $8.55 million, a decrease of -55.48% compared to the previous year's $19.20 million. Losses were -$20.87 million, 8.15% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for HTGM stock is "Buy." The 12-month stock price forecast is 9.75, which is an increase of 61.42% from the latest price.

Price Target
$9.75
(61.42% upside)
Analyst Consensus: Buy